Carregant...
SAT-LB028 Efficacy and Safety of Pramlintide as an Adjunct to Insulin U500 Therapy in Veterans with Severe Insulin Resistance
Background: Obese Type 2 diabetes(T2DM) patients with high insulin resistance may require insulin U500 therapy. There is a lack of safety and efficacy data for the use of Pramlintide (P) as an adjunct therapy with U500 insulin (U500I) to maintain optimal glucose control and effect on daily insulin r...
Guardat en:
| Publicat a: | J Endocr Soc |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Endocrine Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552323/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-LB028 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|